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Gastrointestinal stromal tumors (GISTs) are defined as specific CD117-(Kit, stem cell factor receptor) expressing tumors of the
gastrointestinal (GI) tract. They are believed to originate from the interstitial pacemaker cells of Cajal (ICC) or their progenitor
cells. In horses only a few cases of GISTs are described in the literature. In the present paper the macroscopical, histological,
immunohistochemical, and ultrastructural features of an equine cecal GIST are described.
1. Case History
A 24-year-old, 540 kg, warm-blood gelding was referred to
the Internal Medicine Section of the Equine Department at
the Vetsuisse Faculty of Zurich with colic. The horse was
regularly vaccinated and dewormed. The horse had suﬀered
from colic the previous week and had lost a lot of weight
over the past few months. Five years before, the horse had
undergone a colic surgery, where 5 meters of the small
intestine had to be removed and an end-to-end anastomosis
was performed. Since then it had been without clinical signs.
On initial examination at the Vetsuisse Faculty of Zurich, the
horse had a poor general condition. After rectal palpation,
an impaction of the cranial colon ascendens was suspected
and the horse was treated with dipyrone (25mg/kg iv) and
paraﬃnum liquidum as well as intravenous fluids. The
next day the impaction was still present and the horse was
treated further with hyperinfusion, moderate exercise, and
was fasted. On the third day the gelding had recovered
temporarily, but then relapsed and developed colic again.
This time the medical treatment consisted of dipyrone
(25mg/kg iv), butylscopolamine (60mg iv), and xylazine
(120mg iv). A hematological and biochemical blood exam-
ination, abdominocentesis, gastroscopy, and an ultrasono-
graphic examination of the abdomen were initiated. The
hematological blood examination showed a slight leukocyto-
sis (9,400/µL; 4,700–8,200); the other parameters were within
reference values. The biochemistry was unremarkable. The
abdominal fluid was increased, yellow colored, and turbid
with an increased cell count of 15,825/µL, specific gravity
1019, and protein 19 g/L. The cytological evaluation of the
abdominal fluid showed a slight suppurative inflammation
without neutrophilic degeneration. The gastroscopy showed
no abnormal findings. On the ultrasonographic examination
of the abdomen, two large heterogeneous solid masses of
approximately 10 to 15 cm and 5 cm in diameter located in
the mid and right caudal aspect of the abdomen most likely
associated with the cecal wall could be seen. The suspected
diagnosis of the cecal masses was a neoplasia (malignant
lymphoma or carcinoma) and as a diﬀerential diagnosis an
abscess formation or a granuloma. The horse was euthanized
because of the poor prognosis and a necropsy was performed.
2. Necropsy Findings
Necropsy revealed two masses in the external cecal wall. One
mass of approximately 10 × 10 × 8 cm was attached by a
small stalk of about 1,5 cm in diameter approximately 10 cm
distant to the apex region of the cecum located between
the medial and ventral taenia of the cecum (Figure 1). The
mass was oval shaped with a multilobulated surface and a
red-beige-brown marmorated cross-section. The mass was
soft, partially cystic, and of brittle consistency, separated by
multifocal necrosis and hemorrhage (Figure 2). The second
mass was of transmural (5× 5× 8 cm) and intraluminal (4×
4 × 3 cm) growth, located in the corpus region of the cecum
between themedial and lateral taenia. The nodule was of firm
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Figure 1: Necropsy revealed an approximately 10 × 10 × 8 cm
neoplastic mass attached by a small stalk to the external cecal wall.
Figure 2: Cross-section: brittle consistency, red-beige mottled with
multifocal necrosis/hemorrhage.
texture and of whitish color with central necrosis. Additional
diagnostic finding consisted of an encapsulated foreign body
(piece of wire) of 5 cm length located in the cranial part of
the duodenum with secondary fistula formation. The other
internal organs showed no macroscopic changes.
3. Histologic, Immunohistochemical, and
Electron Microscopic Findings
Tissue samples of the cecum, the jejunum, the liver, and
the tumor were fixed in 4% buﬀered-formalin processed
conventionally and embedded in paraﬃn. Sections of about
2-3 µm were cut and stained with hematoxylin-eosin (HE)
and periodic-acid-Schiﬀ (PAS) and evaluated with light
microscopy.
Histological examination revealed that the mass con-
sisted of well-demarcated densely cellular tissue arranged in
interlacing fascicles or in a storiform pattern with abundant
fibrovascular tumor stroma and moderate mucinous matrix.
The muscle layer of the cecal wall surrounded the extralumi-
nal tumor part. Multifocal acute hemorrhages, edema, and
necrosis were visible. Tumor cell populations showed slight-
to-moderate anisocytosis and anisokaryosis without mitosis.
In the present case the tumor population was of mixed
cell type with about 5% epithelioid cells and about 95%
spindle cells. Cells of epithelioid morphology were round-
to-polygonal-shaped with well-defined cell borders, round-
to-oval nuclei, loosely arranged chromatin, and moderate
eosinophilic cytoplasm. Spindle-shaped cells had indistinct
cell borders, oval nuclei with dispersed granular heterochro-
matin, 1 to 2 small nucleoli, and scant fibrillar cytoplasm
(Figures 3 and 4). The inflammatory response was slight and
mainly composed of lymphocytes, few neutrophils, and some
hemosiderin-loaded macrophages. Multifocal in between
the cell groups and strands, some hyaline brightly bulked
eosinophilic material could be found. These structures were
PAS-positive aggregates of extracellular collagen bundles
known as skeinoid fibers [1, 2]. Additionally a severe focal-
extensive subacute to chronic lymphohistiocytic duodenitis
with formation of moderate fibroangioblastic granulation
tissue due to a foreign body could be diagnosed as an inci-
dental finding.
Immunohistochemical staining was performed for
CD117, vimentin, “alpha smooth muscle actin (SMA),” des-
min, S100, “neuron specific enolase (NSE),” andMelan A. All
sections, except for CD117 and desmin, were pretreated with
a citrated (pH 6) buﬀer for 20 minutes at 98◦C by heating
in a microwave oven. Section for desmin was pretreated in
the same buﬀer only for 5 minutes at 98◦C, and section for
CD117 was pretreated with an alkaline buﬀer (pH 9) for 20
minutes at 98◦C. For vimentin, SMA, desmin, S100, NSE,
and melan A, the Detection-kit ChemMate from DAKO was
used. For CD117 the OUM-kit from Roche was applied and
performed on the discovery machine. Additionally, in all
sections, endogenous peroxidase reaction was blocked with
peroxidase-blocking solution (DAKO S2023). Antibodies
from DAKO against the following antigens were used in the
DAKO Autostainer (DAKO AG Switzerland): CD117 (rabbit,
dilution 1 : 400, DAKO A4502), vimentin (mouse, dilution
1 : 100, DAKO M7020), SMA (prediluted mouse, DAKO
N1584), desmin (prediluted mouse, DAKO N1526), S100
(prediluted rabbit, DAKO N1573), NSE (mouse, dilution
1 : 150, DAKO M087301), and Melan A (mouse, dilution
1 : 10, DAKO M719601). All antibodies were diluted with
dilution buﬀer from DAKO (S2022). The sections were incu-
bated with streptavidin-peroxidase conjugate and reacted
with the substrate-chromogen 3-amino-9-ethylcarbazole
(AEC, Detection-kit DAKO K 5003) at room temperature
and counterstained with hematoxylin. Positive and negative
controls were included. The neoplastic cells had moderate
diﬀuse positive red intracytoplasmic granular staining for
vimentin, showed strong diﬀuse pancytoplasmic homo-
genous to slight granular positive staining for CD117
(Figure 5), and were diﬀusely slight to moderate positive for
NSE. In contrast, the tumor was negative for desmin, S100,
and Melan A (Table 1).
For electron microscopy, one millimeter cubes of for-
malin-fixed and paraﬃn-embedded tumor locations were
selected and further fixed in 2,5% glutaraldehyde in 0,1M
natriumphosphat buﬀer (pH 7,4). Postfixation was per-
formed with 1% osmium tetroxide buﬀered in natriumphos-
phat. After dehydration in graded ethanol series, followed by
propylenoxide, the samples were embedded in Epon resin.
Ultrathin sections were stained with 2% uranyl acetate and
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Table 1: Slight staining (+), moderate staining (++), strong stain-
ing (+++), no reaction (−).
ICH Results
CD117 +++
Vimentin +++
SMA −
Desmin −
S100 −
NSE ++
Figure 3: Predominant spindle-shaped tumor cells with a fascicular
pattern. Spaces between tumor cell trabeculae are filled with ery-
throcytes, siderophages and collagenous (skeinoid fibers) as well as
mucinous matrix (HE).
lead acetate. Samples were examined on a Philips CM 10
transmission electron microscope.
The tumor had a pleomorphic cell population with
indistinct cell borders. The cells had round-to-elongated
nuclei with marked nuclear lobulation and low-to-moderate
peripheral packed chromatin. The cytoplasm contained vari-
able swollen and dilatated mitochondria, low-to-moderate
perinuclear smooth endoplasmic reticulum, and few neu-
rosecretory granules (150 nm) which displayed an ultrastruc-
tural feature of neuronal diﬀerentiation. Foci of interme-
diate filaments and arrays of microtubules were detected.
Furthermore, tumor cells were embedded in an amorphous
matrix and were separated bymoderate dense collagen fibers,
interpreted as interstitial skeinoid fibers.
4. Discussion
GISTs are rather uncommon tumors in horses. To the
author’s knowledge, there are only five publications between
2001 and 2010 reporting on 15 GISTs in 14 horses. A for-
mer study in France could show that thoroughbred horses
(13,43%) and horses older than 10 years (23,90%) were sig-
nificantly more often aﬀected by tumors in general and that
the most frequent tumors were benign (adenomas, lipomas)
[3]. Of the malignant tumors, the alimentary lymphoma is
the most common intestinal neoplasia in horses, followed by
adenocarcinoma and leiomyosarcoma most likely located in
the small intestine, mainly in Arabian horses [4]. GISTs have
been described for decades in humans and more recently
Figure 4: The distinction between epithelioid type (lower side
right) and spindle cell type (upper side left) (HE).
Figure 5: All tumor cells showed strong diﬀuse red pancytoplasmic
homogenous to slight granular positive staining for CD117 (c-kit).
in dogs, nonhuman primates, horses, and rodents (rat and
guinea pig) [5–9]. They are the most common primary
nonlymphoid mesenchymal tumors of the GI tract with
presumed histogenetic origin from the interstitial cells of
Cajal (ICC) or of their pluripotent stem cells (precursor-
cell-hypothesis). Both are Kit-positive cells [10, 11]. Kit is a
transmembrane receptor tyrosine kinase encoded by the c-kit
protooncogene and is nearly consistently expressed in all
GISTs [12]. In addition, the embryonic isoform of smooth
muscle myosin heavy chain is expressed in both GISTs and
ICCs what supports the origin from ICCs [13]. Previously,
these tumors were often misdiagnosed on morphologic basis
as leiomyoma/-sarcomas, or schwannomas. Electron micro-
scopic findings have demonstrated that most human GISTs
derive from primitive mesenchymal cells that undergo either
neurogenic, myogenic, dual, or no diﬀerentiation [14]. In the
present case, without c-kit-staining, the tumor would have
been diagnosed as a neuroendocrine tumor at histological
level showing characteristics of neurogenic diﬀerentiation
(NSE +). Ultrastructural studies revealed that a subgroup of
GISTs seems to derive from the enteric plexi and is therefore
called plexosarcoma or gastrointestinal autonomic nerve
tumor (GANT) [15]. Most equine GISTs seem to be inci-
dental findings at postmortem examination, but a few caused
clinical signs like weight loss, chronic bleeding, anemia, and
recurrent colic [5, 16]. GIST development can be associated
with gain-of-functionmutations of c-kit, a protooncogene in
humans that may lead to autophosphorylation, cellular pro-
liferation, and reduction of apoptosis [17]. Actually, in horses
4 Case Reports in Veterinary Medicine
no genetic investigations for GISTmutations are described in
the literature. This would be important if therapies targeting
the c-kit tyrosine kinase receptor, already available in human
medicine, could be applied in horses. For tumor grading,
the most consistent histologic features applied to predict
malignancy are tumor size and mitotic index. Fletcher et al.
in 2002 classified human GISTs into 4 risk categories: very
low risk, low risk, intermediate risk, and high risk based on
tumor size and mitotic counting [21]. Applying the human
classification, the present tumor would be categorized into
a high-risk tumor because of a size of >10 cm and no
mitotic figures. Other criteria of malignancy were present in
this tumor-like marked cellular pleomorphism, pronounced
anisokaryosis, invasiveness, hemorrhage, and necrosis, but
it still remains diﬃcult to provide an accurate prognosis
for animals [8]. The location of the tumor may also be an
important prognostic factor in human GISTs where a signi-
ficant diﬀerence in site-specific survival could be shown. The
survival curve was very good for GISTs located in the
stomach. In contrast, small-bowel tumors showed a much
poorer prognosis [18]. In horses it depends primarily on the
degree of expansive tumor growth that may result in intes-
tinal obstruction and colic. In the present case, the tumor
was located in the apex and corpus region of the cecum. In
a recent study from Hafner et al. in 1998, most of nine
GISTs from seven horses investigated were also located in
the distal region of the cecum. Thus, the cecum appears
to be a common location in horses and dogs [5, 8, 16].
Curiously, human GISTs occur more often in the stomach
followed by the small intestine [19], and it is interesting to
note that five of seven GISTs in nonhuman primates have
also been found in the stomach [6]. In addition the present
tumor was of multiple incidence, which is in contrast to
a recent study where almost all equine GISTs were solitary
and without detected metastasis in necropsy [16]. However
multiple tumors have been described in old horses, dogs,
and cats, but metastases were rare [14]. Thus it is diﬃcult
to decide whether multifocal tumors may be interpreted as
metastasis or multiple tumor formation. Metastatic GISTs
are described in the literature. In a previous study metastatic
nodules were found in the liver, the spleen, the femur, and the
bone marrow of a F344 rat [7] and widespread abdominal
metastasis were diagnosed in a rhesus macaque [20]. Typical
of malignant human GISTs is intra-abdominal spread and
distant metastases most commonly to the liver followed by
the lung and the bone [18]. Furthermore, vimentin expres-
sion is correlated with a light microscopic diagnosis of malig-
nancy. Thus immunohistochemical staining for vimentin
may be useful in more accurately defining tumors of ques-
tionable malignant behavior [8]. GISTs that are considered
as tumors of malignant behavior need to be surgically
removed. Segmental resection or complete en bloc resec-
tion is the standard treatment in human and equine medi-
cine. Inoperable or metastatic human GISTs are treated with
imatinib mesylate a competitive inhibitor of c-kit (CD117)
[21]. Tumors without CD117 expression but with sim-
ilar morphologic features are called GIST-like tumors
[22]. There was no immunohistochemistry performed on
CD34 (hematopoietic progenitor cell antigen), commonly
immunopositive in human GISTs and in ICCs, because the
antibody did not stain equine control tissue in a recent study
[16]. Besides, in a nonhuman primate none of the neoplastic
cells were immunoreactive for CD34 [7]. The SMA positivity
of human GISTs is about 30–40% and is correlated with
a more favorable prognosis in gastric and small intestine
tumors. In contrast, desmin is rare in human GISTs of all
sites [23]. In the present case, the staining was negative for
both implying nomyogenic diﬀerentiation of the tumor cells.
This is in accordance to previous studies on equine GISTs
[5, 16]. As human GISTs, equine tumors occur in mature
adults and more often in mares [5], but case numbers are
limited. Finally in the present case, the foreign body located
in the cranial part of the duodenum might also have caused
digestion disturbance and recurrent colic, so that we cannot
explain whether the foreign body, the GIST, or both had
caused the clinical signs. In summary, the tumor presented
here was diagnosed as a GIST because of positive expression
of CD117 and vimentin, immunonegativity for desmin, and
variable staining features for SMA, S100, and NSE depending
on the tumor diﬀerentiation. Immunohistochemical and
ultrastructural features suggested a tumor of the neural type
according to the classification from Rosai in 1996 [24].
This study demonstrated once more the necessity of immu-
nohistochemical staining of c-kit to support the diagnosis of
a GIST.
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